PROVIDER PROFILE · NPI 1972521623
Michael KletzM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,207
Unique beneficiaries
—
Total services
12,951
Distinct HCPCS
9
Medicare payment
$194K
Peer benchmark
Total Medicare services vs. 108 Allergy/ Immunology providers in VA — top quintile (cohort median 3,446).
PRESCRIBING · PART D · 2024
Total Rx claims
581
Beneficiaries
—
Total drug cost
$31K
Distinct drugs
14
Brand share
12.6%
Top prescribed drugs
Montelukast Sodium149 claims
Desloratadine81 claims
Levocetirizine Dihydrochloride72 claims
Ipratropium Bromide47 claims
Olopatadine Hcl45 claims
QUALITY · MIPS · 2024
Final MIPS score
96.8
Quality
100.0
Cost
89.2
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.92%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Michael Kletz's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Appaji Gondi Allergy/ Immunology · Mc Lean, VA | 262 | 2,021 |
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 102 | 389 |
| UVA PRINCE WILLIAM MEDICAL CENTER | 30 | 62 |
| SOLSTAS LAB PARTNERS GROUP LLC | 28 | 141 |
| Quest Diagnostics Nichols Institute, Inc. Clinical Laboratory · Chantilly, VA | 27 | 54 |
| LUCY WEBB HAYES NATIONAL TRAINING SCHOOL FOR DEACONESSES & MISSIONARIE | 15 | 37 |
| Sunrise Medical Laboratories, Inc. Clinical Laboratory · Hicksville, NY | 15 | 76 |
| RESTON HOSPITAL CENTER LLC | 14 | 45 |
| UVA PRINCE WILLIAM MEDICAL CENTER | 13 | 28 |
| BETHESDA DERMATOPATHOLOGY LAB INC. | 11 | 27 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE